Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2017-03-14, 10:25:37 | version 1.49.03
HIGHLIGHTS 2016 1 PERSONNEL – PRIZES AND ENCOUNTERS Inauguration of extension-build in Straubing 1 GreenTec Award for anti-icing coatings 2 With a ceremony and the symposium “Power-to-X”, the IGB branch Bio, Electro and Chemocatalysis BioCat in Straubing oficially opened its extension-building on March 9, 2016. Guests from science and industry as well as political repre- sentatives came to Straubing for the solemn inauguration; attendees included the Parliamentary State Secretary at the German Federal Ministry of Education and Research (BMBF), Stefan Müller, and the State Secretary at the Bavarian State The GreenTec Awards 2016, European´s most important awards for environmental technology, were presented on May 29, 2016 at a festive gala held to open the IFAT fair in Munich. Fraunhofer IGB received second prize in the category of “Avia- tion” for the self-adhesive anti-icing coatings developed at the institute. Ministry of Economic Affairs, Media, Energy and Technology, Franz Pschierer. Research Scholar Award for international eye research to Katja Schenke-Layland Honorary professorship for Dr. Christian Oehr For his achievements at Stuttgart University, Dr. Christian Oehr was appointed the title of honorary professor by the university senate. With this award, the university honors the many years of teaching of the acting IGB institute director who has been teaching at the Energy Technology, Process Engineering and Biological Engineering Faculty since 1996. In June 2016, Prof. Dr. Katja Schenke-Layland was awarded the Harold F. Spalter International Research Scholar Award of the American Organization “Research to Prevent Blindness (RPB)”. The award means that the scientist will be able to commence strategic cooperation with the Eye Institute of the Keck School of Medicine at the University of Southern Califor- nia (USC). The aim is the development of an in vitro model of the lacrimal gland to develop stem cell-based treatments for people suffering from the Sjögren’s syndrome. 2 8